Cite
HARVARD Citation
Spelman, T. et al. (n.d.). Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis. European journal of neurology. pp. 729-736. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Spelman, T. et al. (n.d.). Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis. European journal of neurology. pp. 729-736. [Online].